South Georgia Toxicology, INC

South Georgia Toxicology, INC was paid $2.83M by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 74% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#18 of 66

Median peer was paid$178K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	34,132	$186K
2019	44,064	$343K
2020	44,047	$448K
2021	19,372	$462K
2022	12,559	$436K
2023	8,931	$544K
2024incomplete	20,028	$414K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	74%	17,020	14,672	$2.09M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	6.1%	2,237	2,112	$174K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.2%	12,303	9,493	$147K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.0%	1,087	968	$57K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	1.4%	2,522	2,165	$41K
80356		<1%	5,765	4,881	$25K
83992		<1%	5,007	4,187	$14K
80361		<1%	5,791	4,895	$14K
80367		<1%	5,328	4,479	$13K
80323		<1%	5,778	4,887	$12K
80347		<1%	4,165	3,412	$12K
80321		<1%	3,397	2,858	$12K

31 more codes

80357		<1%	5,276	$12K
80373		<1%	4,156	$11K
80372		<1%	4,113	$11K
80366		<1%	4,395	$11K
80370		<1%	4,326	$11K
80355		<1%	4,546	$11K
80368		<1%	3,570	$11K
80365		<1%	5,806	$10K
80354		<1%	5,799	$10K
80358		<1%	5,852	$10K
80348		<1%	5,796	$10K
80359		<1%	5,777	$10K
80353		<1%	5,767	$9K
80371		<1%	4,853	$8K
80345		<1%	4,205	$8K
80338		<1%	3,392	$7K
80333		<1%	3,240	$7K
80363		<1%	3,643	$7K
80336		<1%	3,253	$7K
80364		<1%	1,992	$6K
80342		<1%	2,803	$6K
80349		<1%	5,082	$6K
80350		<1%	5,109	$5K
80360		<1%	2,050	$5K
80324		<1%	3,701	$5K
80325		<1%	2,024	$5K
80346		<1%	1,227	$2K
80369		<1%	65	$154.57
80332		<1%	732	$29.70
82570		0%	73	$0.00
81003		0%	110	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDRAMBEL, ED (OWNER)